115 related articles for article (PubMed ID: 35718262)
1. Changes in diagnostic usefulness of the JRS scoring system in COVID-19 pneumonia by SARS-CoV-2 vaccination.
Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y; Nomura S
J Infect Chemother; 2022 Oct; 28(10):1375-1379. PubMed ID: 35718262
[TBL] [Abstract][Full Text] [Related]
2. Is the JRS atypical pneumonia prediction score useful in detecting COVID-19 pneumonia under nursing or healthcare settings?
Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y; Ito T
Respir Investig; 2024 Mar; 62(2):187-191. PubMed ID: 38185019
[TBL] [Abstract][Full Text] [Related]
3. Validation of JRS atypical pneumonia score in patients with community-acquired Chlamydia psittaci pneumonia.
Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y
J Infect Chemother; 2023 Sep; 29(9):863-868. PubMed ID: 37207957
[TBL] [Abstract][Full Text] [Related]
4. Invalidity of JRS atypical pneumonia prediction score in Omicron variant of COVID-19 pneumonia.
Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y; Ito T
Respir Investig; 2024 May; 62(3):384-387. PubMed ID: 38452443
[TBL] [Abstract][Full Text] [Related]
5. Influence of age on the clinical differentiation of atypical pneumonia in adults.
Miyashita N; Kawai Y; Akaike H; Ouchi K; Hayashi T; Kurihara T; Okimoto N
Respirology; 2012 Oct; 17(7):1073-9. PubMed ID: 22563979
[TBL] [Abstract][Full Text] [Related]
6. Early identification of novel coronavirus (COVID-19) pneumonia using clinical and radiographic findings.
Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y; Nomura S
J Infect Chemother; 2022 May; 28(5):718-721. PubMed ID: 35190258
[TBL] [Abstract][Full Text] [Related]
7. Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults.
Miyashita N; Kawai Y; Yamaguchi T; Ouchi K; Oka M;
Eur J Clin Microbiol Infect Dis; 2011 Mar; 30(3):439-46. PubMed ID: 21061035
[TBL] [Abstract][Full Text] [Related]
8. [To evaluate the auxiliary diagnostic value of Japanese respiratory society scoring system for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in inpatients with community acquired pneumonia].
Yuan X; Jin X; Niu W; Cui Q; Liu H; Zheng J; Heng Z; Bai C
Zhonghua Jie He He Hu Xi Za Zhi; 2015 Jul; 38(7):497-500. PubMed ID: 26703014
[TBL] [Abstract][Full Text] [Related]
9. Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
Britton A; Fleming-Dutra KE; Shang N; Smith ZR; Dorji T; Derado G; Accorsi EK; Ajani UA; Miller J; Schrag SJ; Verani JR
JAMA; 2022 Mar; 327(11):1032-1041. PubMed ID: 35157002
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
11. Atypical pneumonia due to SARS-CoV-2: Clinical differentiation using the JRS pneumonia guidelines.
Miyashita N
Respir Investig; 2022 Nov; 60(6):735-737. PubMed ID: 36115794
[No Abstract] [Full Text] [Related]
12. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Japanese Respiratory Society guidelines for the identification of Mycoplasma pneumoniae pneumonia.
Yin YD; Zhao F; Ren LL; Song SF; Liu YM; Zhang JZ; Cao B
Respirology; 2012 Oct; 17(7):1131-6. PubMed ID: 22805282
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
Torres I; Bellido-Blasco JB; Gimeno C; Burgos JS; Albert E; Moya-Malo R; Gascó-Laborda JC; Tornero A; Soriano J; Meseguer-Ferrer N; Martínez-Serrano M; Ortíz-Rambla J; Buj H; Hernández N; Peiró S; Salas D; Limón R; Vanaclocha H; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Navarro D;
J Med Virol; 2022 Aug; 94(8):3776-3782. PubMed ID: 35445415
[TBL] [Abstract][Full Text] [Related]
15. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
[TBL] [Abstract][Full Text] [Related]
16. Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load.
Migueres M; Dimeglio C; Trémeaux P; Raymond S; Lhomme S; Da Silva I; Oliveira Mendes K; Abravanel F; Félicé MP; Mansuy JM; Izopet J
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215916
[TBL] [Abstract][Full Text] [Related]
17. Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2.
Chun JY; Jeong H; Kim Y
JAMA Netw Open; 2022 Mar; 5(3):e223064. PubMed ID: 35302625
[TBL] [Abstract][Full Text] [Related]
18. A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants.
Wu D; Ye Y; Tang L; Wang AB; Zhang R; Qian ZH; Wang FZ; Zheng H; Huang C; Lv XY; Wang HF; Zhang YY; Pan JJ; Li YF; Lu MX; Wang CS; Ma YT; An ZJ; Rodewald LE; Yin ZD; Wang XY; Wu ZY; Shao YM
Emerg Microbes Infect; 2022 Dec; 11(1):1950-1958. PubMed ID: 35850623
[TBL] [Abstract][Full Text] [Related]
19. An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward.
Wi YM; Kim SH; Peck KR
J Korean Med Sci; 2022 Jan; 37(4):e28. PubMed ID: 35075827
[TBL] [Abstract][Full Text] [Related]
20. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
